John Edward Knighton
Vice President, Cell & Gene Therapy API Development, Janssen Pharmaceuticals


Dissertation: Biosimilars: New Look on Process Innovation and the Impact on Competitive Dynamics.

With over 20 years of pharmaceutical experience, John Knighton has held a number of roles with increasing responsibilities within the biopharmaceutical field. Currently, John is a Senior Scientific Director at Janssen Pharmaceuticals, part of the Johnson & Johnson Family of Companies, leading a diverse and dedicated team of managers, scientists, and engineers in biopharmaceutical process development, global technology transfer, and technical commercial product support. John started his career at SmithKline Beecham and GlaxoSmithKline working there for 14 years in various roles in biopharmaceutical research and development.

John earned his MBA from Villanova University, a DBA from the Fox School of Business, and a Bachelor of Science degree in Microbiology from The Pennsylvania State University.